Welcome to our dedicated page for The Beauty Health Company SEC filings (Ticker: SKIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding how much HydraFacial’s revenue comes from high-margin serums versus capital equipment can feel like searching for a pore in the dark. The Beauty Health Company annual report 10-K simplified still runs well over 200 pages, and critical warranty, margin, and supply-chain details rarely sit in one place. If you have ever typed “The Beauty Health Company SEC filings explained simply” after another late-night scroll through footnotes, you are not alone.
Stock Titan removes that friction. Our platform ingests every disclosure the moment it hits EDGAR and delivers plain-English answers to the questions professionals actually ask, from “understanding The Beauty Health Company SEC documents with AI” to “The Beauty Health Company quarterly earnings report 10-Q filing.” You will see:
- Real-time alerts on The Beauty Health Company Form 4 insider transactions—watch executive stock moves minutes after they file.
- At-a-glance breakouts of consumable-versus-device sales inside each 10-Q.
- One-click access to The Beauty Health Company proxy statement executive compensation with AI commentary on incentive metrics tied to HydraFacial unit growth.
Need “The Beauty Health Company 8-K material events explained” when a new product launches? Want a single dashboard for The Beauty Health Company insider trading Form 4 transactions as well as “The Beauty Health Company executive stock transactions Form 4” in real-time? Or perhaps a concise “The Beauty Health Company earnings report filing analysis” before the market opens? Our AI-powered summaries highlight segment margins, recurring revenue ratios, and geographic trends so you can act quickly instead of parsing PDF jargon. Save hours, spot opportunities, and stay ahead with comprehensive coverage—every filing, every time.
Janus Henderson Group plc reports beneficial ownership of 5,718,565 shares of The Beauty Health Company, representing 4.5% of the class. The filing indicates shared voting and shared dispositive power over those shares while noting no sole voting or dispositive power. The reporting person is organized in Jersey and identified as an investment adviser/holding company (IA, HC). The statement also discloses that indirect subsidiaries (JHIUS, JHIUKL and JHIAIFML) act as registered investment advisers providing advice to Managed Portfolios.
The Beauty Health Company (SKIN) Form 4 reports a non-sale withholding of shares by Chief Financial Officer Michael P. Monahan related to the vesting of restricted stock units. On 08/10/2025, 32,357 shares were withheld to satisfy tax withholding at a recorded price of $1.89 per share. The disclosure states this withholding "does not represent a sale." Following the transaction, the reporting person’s beneficial ownership is shown as 1,326,305 shares.
This filing documents an internal compensation settlement (tax withholding on vested RSUs) rather than an open-market transaction, and it clarifies the officer’s post-transaction share count.
Form 4 Overview – The Beauty Health Company (SKIN)
Director Desiree Gruber filed a Form 4 reporting the award of 73,051 Class A common-stock RSUs on 16 June 2025. The award was coded “A” (acquired) and represents equity compensation rather than an open-market purchase. After this grant, Gruber’s total beneficial ownership rises to 192,565 shares, all held directly.
Vesting Terms
- The RSUs vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the 2026 annual meeting of shareholders.
- Continuous board service is required through the vesting date.
Key Takeaways for Investors
- The filing signals continued board-level alignment with shareholders, although the grant is part of the regular director compensation program rather than a discretionary purchase.
- No derivative securities transactions were reported, and no shares were disposed of.
- The transaction does not alter the company’s cash position or share count today, but it will have a modest dilutive effect upon vesting.
Form 4 filing for The Beauty Health Company (SKIN) discloses that director Michelle C. Kerrick was granted 73,051 restricted stock units (RSUs) on 06/16/2025 (Transaction Code A).
• The RSUs vest on the earlier of the one-year anniversary of the grant or the date of the company’s 2026 annual shareholders’ meeting, subject to her continued board service.
• After the grant, Kerrick’s total beneficial ownership increases to 189,813 Class A shares, held directly.
• No derivative securities were involved and no shares were sold.
The filing represents routine director equity compensation and does not indicate any open-market buying or selling activity.
Beauty Health Company (ticker: SKIN) filed a Form 4 disclosing an insider equity grant. Director Brian Christopher Miller received 73,051 Class A common-stock RSUs on 16 June 2025. The award is classified as an acquisition (Code A) and is part of routine director compensation.
The RSUs will vest on the earlier of the one-year anniversary of the grant or the 2026 annual shareholder meeting, subject to Miller’s continued board service. Following the grant, Miller’s beneficial ownership increased to 243,035 shares, held directly. No derivative securities or sales were reported, and no 10b5-1 trading plan was indicated.
Beauty Health Company (SKIN) – Form 4 insider filing
Director Doug K. Schillinger reported the grant of 73,051 restricted stock units (RSUs) on 16 Jun 2025. The award is coded "A" (acquisition) and is part of the company’s director compensation program rather than an open-market purchase. Vesting occurs on the earlier of (i) the one-year anniversary of the grant or (ii) the 2026 annual shareholders’ meeting, subject to the director’s continued board service.
Following this grant, Schillinger’s total beneficial ownership increased to 216,035 Class A common shares, all held directly. No derivative securities were reported.
The filing signals continued equity-based alignment between the board and shareholders but does not, by itself, alter Beauty Health’s financial outlook or capital structure.
FAQ
What is the current stock price of The Beauty Health Company (SKIN)?
What is the market cap of The Beauty Health Company (SKIN)?
